Company / Working Capital
Regenerative Medical Technology Group Inc. Working Capital History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$35.6M
FY2025
5-year range
-$35.6M / -$1.2M
FY2021-FY2025
Trend
-28.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has declined for 5 consecutive years, from -$871,941 in FY2020 to -$36M in FY2025.
Based on SEC 10-K filings.
-$36M in FY2025.
Declined from -$22M to -$36M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Regenerative Medical Technology Group Inc.'s working capital has declined for 5 consecutive years.
- In FY2025, working capital decreased 28.4% year-over-year.
- Peak working capital was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$35.6M | -28.4% |
| FY2024 | -$27.7M | -27.9% |
| FY2023 | -$21.7M | -110.3% |
| FY2022 | -$10.3M | -760.1% |
| FY2021 | -$1.2M | -37.4% |
| FY2020 | -$871.9K | +87.4% |
| FY2019 | -$6.9M | -52.9% |
| FY2018 | -$4.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026